Philippine Genome Center
From Wikipedia, the free encyclopedia
![]() | |
| Established | 2009 |
|---|---|
| Research type | Basic and Applied |
Field of research | Genomics |
| Director | Cynthia Saloma |
| Location | Quezon City, Philippines 14°39′06″N 121°04′18″E / 14.65157°N 121.07168°E |
| Affiliations | University of the Philippines Diliman |
| Website | pgc |
| Map | |
The Philippine Genome Center (PGC) is a multi-disciplinary research facility in Quezon City, Metro Manila, Philippines which specializes in genomics.
COVID-19 pandemic in the Philippines
The Philippine Genome Center was established as a collaboration between the University of the Philippines and the Department of Science and Technology (DOST).[1] It was first conceptualized in 2009 in response to the SARS outbreak which affected Hong Kong, the dengue outbreaks which affecting the Philippines, and the then-ongoing H1N1 flu pandemic which originated in Mexico. The first grants received by the PGC were for dengue diagnostic testing and H1N1 surveillance.[2] Initially the facility was placed under the jurisdiction of the University of the Philippines (UP) Diliman's Office of the President as per the approval of the UP Board of Regents in its July 31, 2009 meeting.[3]
The PGC was formally launched on November 28, 2011. In the beginning, the center operated virtually. From January 2013 until the opening of its building on September 11, 2019,[4] it was temporarily housed at the National Institute of Molecular Biology and Biotechnology at UP Diliman
To make DNA sequencing and bioinformatics services accessible to Filipino researchers, the DNA Sequencing Core Facility (DSCF) and Core Facility for Bioinformatics (CFB) were established with funding support from the DOST. On February 26, 2016, the UP Board of Regents approved the transfer of management and supervision of the PGC from the university's Office of the President to the Office of the Vice President for Academic Affairs[3]
In 2019, PGC Mindanao[5] and PGC Visayas[6] were established as satellite offices in Mindanao and Visayas respectively.
In January 2020, the PGC in collaboration with UP Manila National Institutes of Health developed an RT-PCR SARS CoV-2 detection kit.[7]
In April 2020, the Department of Health has set the Philippine Genome Center as the 18th coronavirus testing hub.[8] It was also tasked to conduct genomic sequencing of COVID-19 samples.[9] In July 2021, PGC Mindanao and PGC Visayas was also given the task of detecting new variants with the plan on giving them machines to conduct genome sequencing.[10] In September 2021, the PGC has shifted its focus towards detecting new COVID-19 variants in the country and less focus on conducting RT-PCR tests.[11]
